LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109. A total of 18 filers reported holding LOMBARD MED INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $337,000 | – | 249,603 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 886,363 | $6,380,000 | 1.84% |
| FIL Ltd | 868,728 | $6,255,000 | 0.02% |
| Verition Fund Management LLC | 24,110 | $174,000 | 0.02% |
| Alyeska Investment Group, L.P. | 109,034 | $785,000 | 0.02% |
| GLG Partners LP | 60,892 | $438,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 54,000 | $388,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000 | $288,000,000 | 0.01% |
| Ground Swell Capital, LLC | 200 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,159 | $16,000 | 0.00% |
| AXA S.A. | 17,154 | $124,000 | 0.00% |